Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Apo Trifluoperazine
2. Apo-trifluoperazine
3. Apotrifluoperazine
4. Eskazine
5. Flupazine
6. Stelazine
7. Terfluzine
8. Trifluoperazine
9. Trifluoperazine Hcl
10. Trifluoroperazine
11. Trifluperazine
12. Triftazin
1. Trifluoperazine Dihydrochloride
2. 440-17-5
3. Stelazine
4. Trifluoperazine 2hcl
5. Terfluzine
6. Trifluoperazine Hcl
7. Triphthazine
8. Eskazinyl
9. Jatroneural
10. Triftazin
11. Tryptazine
12. Trazine
13. Trifluoroperazine Hydrochloride
14. Tryptazine Dihydrochloride
15. Fluoperazine
16. Eskazine
17. Triphthazine Dihydrochloride
18. Calmazine
19. Modalina
20. Stalazine Hydrochloride
21. Trifluoroperazine Dihydrochloride
22. Stelazine Dihydrochloride
23. Trifluoperazine (dihydrochloride)
24. Skf 5019
25. Trifluperazine Dihydrochloride
26. 10-(3-(4-methylpiperazin-1-yl)propyl)-2-(trifluoromethyl)-10h-phenothiazine Dihydrochloride
27. 10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)-10h-phenothiazine Dihydrochloride
28. Fluoperazine Dihydrochloride
29. 6p1y2snf5v
30. 10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)phenothiazine Dihydrochloride
31. 10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine;dihydrochloride
32. 10h-phenothiazine, 10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-, Dihydrochloride
33. Nsc-757369
34. 10h-phenothiazine, 10-[3-(4-methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-, Dihydrochloride
35. Dsstox_cid_25085
36. Dsstox_rid_80660
37. Dsstox_gsid_45085
38. 10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine Dihydrochloride
39. Chebi:9710
40. Sr-01000003020
41. Ncgc00186653-01
42. Trifluoperazine Hydrochloride (van)
43. Trifluoperazine Hydrochloride [jan]
44. Cas-440-17-5
45. Einecs 207-123-0
46. Unii-6p1y2snf5v
47. Triphthasine
48. Ai3-50137
49. Stelazine (tn)
50. Prestwick_482
51. Mfcd00012656
52. Trifluoperazine Dihcl
53. Trifluoperazine Hydrochloride [usp:jan]
54. Schembl341516
55. Spectrum1500591
56. Chembl1257040
57. Dtxsid1045085
58. Hy-b0532a
59. Skf5019
60. Hms1568p08
61. Hms1921g15
62. Skf-5019
63. Tox21_110017
64. Tox21_501232
65. Ccg-40290
66. S3201
67. Akos015895085
68. Tox21_110017_1
69. Ac-8081
70. Ks-5109
71. Lp01232
72. Sb19410
73. Phenothiazine, 10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-, Dihydrochloride
74. Ncgc00013226-01
75. Ncgc00094474-01
76. Ncgc00094474-02
77. Ncgc00094474-03
78. Ncgc00261917-01
79. Trifluoperazine Hydrochloride (jan/usp)
80. Trifluoperazine Dihydrochloride, >/=99%
81. Trifluoperazine Dihydrochloride [mi]
82. Eu-0101232
83. Ft-0600798
84. Sw168675-6
85. T-175
86. T2849
87. Trifluoperazine Hydrochloride [mart.]
88. Trifluoperazine Hydrochloride [vandf]
89. Trifluoperazine Hydrochloride [usp-rs]
90. Trifluoperazine Hydrochloride [who-dd]
91. C75189
92. D00799
93. T 8516
94. Trifluoperazine Dihydrochloride, >=99%, Powder
95. A826478
96. Trifluoperazine Hydrochloride [orange Book]
97. Sr-01000003020-2
98. Trifluoperazine Hydrochloride [ep Monograph]
99. Trifluoperazine Hydrochloride [usp Monograph]
100. W-106212
101. Q27108478
102. Sr-01000003020-10
103. Trifluoperazine Hydrochloride, Meets Usp Testing Specifications
104. Trifluoperazine Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
105. 10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine;dihydrochloride.
106. 2-trifluoromethyl-10-[3-(1-methyl-4-piperazinyl)propyl]phenothiazine Dihydrochloride
107. Trifluoperazine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
108. Trifluoperazine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
109. 10h-phenothiazine, 10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-, Hydrochloride (1:2)
110. Trifluoperazine Dihydrochloride Solution, 1.0 Mg/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material
| Molecular Weight | 480.4 g/mol |
|---|---|
| Molecular Formula | C21H26Cl2F3N3S |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 4 |
| Exact Mass | 479.1176589 g/mol |
| Monoisotopic Mass | 479.1176589 g/mol |
| Topological Polar Surface Area | 35 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 510 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
| 1 of 2 | |
|---|---|
| Drug Name | Trifluoperazine hydrochloride |
| Drug Label | Each film-coated tablet, for oral administration, contains trifluoperazine hydrochloride, USP equivalent to 1 mg, 2 mg, 5 mg, or 10 mg trifluoperazine.The structural formula is:C21H24F3N3S2HCl M.W. 480.43C21H24F3N3S2... |
| Active Ingredient | Trifluoperazine hydrochloride |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | eq 5mg base; eq 2mg base; eq 1mg base; eq 10mg base |
| Market Status | Prescription |
| Company | Sandoz; Mylan |
| 2 of 2 | |
|---|---|
| Drug Name | Trifluoperazine hydrochloride |
| Drug Label | Each film-coated tablet, for oral administration, contains trifluoperazine hydrochloride, USP equivalent to 1 mg, 2 mg, 5 mg, or 10 mg trifluoperazine.The structural formula is:C21H24F3N3S2HCl M.W. 480.43C21H24F3N3S2... |
| Active Ingredient | Trifluoperazine hydrochloride |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | eq 5mg base; eq 2mg base; eq 1mg base; eq 10mg base |
| Market Status | Prescription |
| Company | Sandoz; Mylan |
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
Dopamine Antagonists
Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
ABOUT THIS PAGE
A Trifluoperazine Dihydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trifluoperazine Dihydrochloride, including repackagers and relabelers. The FDA regulates Trifluoperazine Dihydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trifluoperazine Dihydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Trifluoperazine Dihydrochloride supplier is an individual or a company that provides Trifluoperazine Dihydrochloride active pharmaceutical ingredient (API) or Trifluoperazine Dihydrochloride finished formulations upon request. The Trifluoperazine Dihydrochloride suppliers may include Trifluoperazine Dihydrochloride API manufacturers, exporters, distributors and traders.
Trifluoperazine Dihydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Trifluoperazine Dihydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Trifluoperazine Dihydrochloride GMP manufacturer or Trifluoperazine Dihydrochloride GMP API supplier for your needs.
A Trifluoperazine Dihydrochloride CoA (Certificate of Analysis) is a formal document that attests to Trifluoperazine Dihydrochloride's compliance with Trifluoperazine Dihydrochloride specifications and serves as a tool for batch-level quality control.
Trifluoperazine Dihydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Trifluoperazine Dihydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Trifluoperazine Dihydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Trifluoperazine Dihydrochloride EP), Trifluoperazine Dihydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trifluoperazine Dihydrochloride USP).
LOOKING FOR A SUPPLIER?
